1. Home
  2. BRAG vs GRDX Comparison

BRAG vs GRDX Comparison

Compare BRAG & GRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bragg Gaming Group Inc.

BRAG

Bragg Gaming Group Inc.

HOLD

Current Price

$1.75

Market Cap

42.0M

Sector

Technology

ML Signal

HOLD

Logo GridAI Technologies Corp.

GRDX

GridAI Technologies Corp.

N/A

Current Price

$4.27

Market Cap

39.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BRAG
GRDX
Founded
2018
N/A
Country
Canada
United Kingdom
Employees
N/A
2
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.0M
39.3M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
BRAG
GRDX
Price
$1.75
$4.27
Analyst Decision
Hold
Analyst Count
2
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
25.4K
106.9K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$6.67
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.42
$1.87
52 Week High
$4.78
$6.93

Technical Indicators

Market Signals
Indicator
BRAG
GRDX
Relative Strength Index (RSI) 52.24 43.83
Support Level $1.60 $2.16
Resistance Level $1.83 $5.30
Average True Range (ATR) 0.09 0.61
MACD 0.01 -0.25
Stochastic Oscillator 79.81 4.95

Price Performance

Historical Comparison
BRAG
GRDX

About BRAG Bragg Gaming Group Inc.

Bragg Gaming Group Inc is predominantly a B2B online gaming technology platform and casino content aggregator. The company's proprietary studios offer high-performing, data-driven casino gaming titles from in-house brands Wild Streak, Spin, Atomic Slot Lab, Indigo Magic, and Oryx Gaming. It offers a full range of games including slot games, table games, card games, video bingo, scratch card games, virtual sports, and live dealer games which are featured on the company's PAM platform and also available for use on other gaming platforms offered by third parties. Geographically, the company generates a majority of its revenue from Malta, and the rest from Netherlands, Curacao, the United States, Croatia, Marshall Islands, Brazil, Isle of Man, Belgium, Czech Republic, and other regions.

About GRDX GridAI Technologies Corp.

GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.

Share on Social Networks: